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Methods 
Paticnt selection. From January through Septrmbrr 1986. 
emergency coronary bypass surgery ‘was performed on 24 of 
386 conseccdve patients enrolled intO the Thrombolysir and 
Angtoplasty in Myocardial Infarction (TAM0 trial of intra- 
venous ti)suc plesminugen activator and coronary angio- 
plasty therapy for acute myocardisl infarction. The details of 
the study de& have heen reported previously (101. Enroll- 
ment criteria included chest paix of <6 h duration and =I 
mm ST segment elevation in two or more contiguous elec- 
trocardiographlc (ECG) leads. Exclusion criteria included 
uge >?5 years. history of recent stroke, surgery or trauma. 
prcdiaoosition to hemorrhage. prior coronary bypass sur- 
gery. &or Q wave infarction in the acutely ischemic region 
nnd cardiogenic shock (blood pressure <KS mm Hg unre- 
sponsive to volume infusion). 
Interventional protocol. Informed consent was obtained 
from the patient before treatment with intmvenous tissue 
plasmmopcn activator. For the first I78 patients enrolled in 
the TAMI trial. the dose was M) mg over h. 20 mg over the 
next 2 h and IO ma for each of the last 5 h of infusion. In the 
remaining 208 pat&s, the dose was I.0 mg/kg body weight 
to a maxunurn of90 mg over I h. with the remaining amount 
of b~sue plasminogen activator (of a I10 mg total) being 
equally divided over a 5 h maintenance infusion. For both 
intravenous regimens. IO’% OS rhc initial (I h) dose was 
administered as a bolus. In p&n& operated on during the 
continuous infusion stage, the tissue plarminogcn activator 
infusion was maintained until !he +nl of the surgical proce. 
dure. 
Sdertire roronory ang5~aphy and le.0 wnwiunlogm- 
phy were performed 90 min after initiation of tissue plasmi. 
no~en activator thcrapv, and patients were grottoed as 
follows: II ~50% residkl stenosis; 2) >50% residuei steno- 
sis with Thrombotvsis in Myocnrdial infarction (TIMI) trial 
Srade II or III flbw and coronary anatomy suitable for 
angioplaty: 3) persistent occlusion (TIMI grddc 0 to 1 Row): 
and 41 >5G% rcsi.<ual stenosis with TIMI grade II or Ill Row 
and coronary anatomy unsuitable for angmpl;:s!y. Patients in 
GrowV 2 were randomized to immediate or elective (predis- 
charge) coronary angioptsrty. 
Sorrific crirerio for erchrsiw from m~~domirarin~t wrc: 
I) ;50% left main coronary &osis with lefl anterior 
desceadine or circumflex infarct-related vessel of ~15% left 
main cor&ry anery stenosis with right coronary infarct- 
rcla1r.d vcsxl; 2) scverc diffuse coronary atherosclerosis 
unsunable for coronary angioplasty; 3) pdiicms in whom the 
infarct ve~scl could not be detcrmincd: and 4) cardiogenic 
shock developing after initiatiun of thrombolytic therapy. 
Patients with persistent coronary occlusion !failurc ofthrom- 
bolysis) or those who developed cardiogenic shock aftel 
en~olhncnt underwent emergency coronary angioplasty 
without randomiration if tbc coronary anatomy was *uitahle. 
Coronary nng;oPIo~y wns attempted using u steerable 
dilation sys!ern. A coronarv nerfu+m cilthrter (Advanced 
Cardiovascumr Systems) WRS placed, when feasibie. in pa- 
tients with unsuccessful angioplarty. This 4.3F catheter has 
:6 side holes armnScd in a spiral fashion along its distal IO 
cm. an arrangement thal allows palsatile blued flow to alter 
proximally and exist distally when the catheter is positioned 
approximately acn~s the coronary occlusion (11.12~. The 
catheter is usually advanced into the coronary artery over an 
exchange cuidc wire and is intermittentlv Rushed with hepa- 
rinired-s&ion. All patients received- heparin. 5,OMl U. 
intravenously before the angiographic procedure and an 
additional 5,Mx) U intravenously if coronary anpioplasty was 
performed. A continuous hepzrin infusion of 300 to 5QQ Ulh 
was begun after termination of the interventional procedure 
and WBF continued until the time of corotmry bypass surgery 
when applicable. 
Toral ~ordiopalmonary bypau and hypothermic cardio- 
plegic soludon were used with standard aortic cross- 
clamping techniques. Patients who survived and consented 
underwent repeat sr.iective coronary nngioplasty and left 
venlriculography befor. hospital discharge. 
Analysis of left venlr~ular function. Outlines of right 
anterior oblique contrast ventriculograms obtained both 
before operation and before discharge were traced manually 
by nn independent observer at the core angiographic labora- 
torv at the University of Michiaan who was unaware ofother 
pa&t data. Left ventricular-ejection fraction was deter- 
mined by the area-length method (13). Regional wall motion 
was determined by the computeras~isted center line chord 
method described by flolson et al. (14) and expressed as 
standard deviations (SD) per chord. Representative end- 
diastolic and end-systolic frames were digitized and stored in 
the metnory of a digital radiographic computer (DPS 4lCK. 
ADAC Laboratoriss) for pmccrsing. Ve&xiugraoij iiirr 
hidered technically inadequate because of ventricular ecto- 
fxc beats or inad&ate ~pacification were not included in 
the analysis. Both early and late global and regional left 
ventricular function were analyrcd for the entire group. as 
well as for subsets of patients with single or multivessel 
disease and in patients operated on <6 or >6 h after the 
~nsct of symptoms. 
Data colleelian and management. Findings in the trial 
were collected by the study nurses and reviewed by the 
principal investigator at each clinical site. Date entry was 
performed at each clinical site and at the coordinating 
center. Any discrepancies in data entry lrsutted in primary 
review of the patient’s records. 
Statistical anal&. All values recorded are nttan f SD. 
Because ventricuisr function was the primary end point of 
lbe TAMI trial. small cha! -s in clobal and reeional left 
ventricular function for the &tire Goup were &tyzed for 
statistical significance usiy the Wilcoxon rank sum test. 
Statistical test3 were not performed for the remainder of the 
clinical dala prerented because II wilh small sample\ the 
likelihood is high of failing 10 detect real differrnces ltypc II 
error); and 2) the muhiplicity of por*ible compariwnb in- 
creases the risk of declaring the presence of cffcct\ ihat iarc 
spurious we I error). 
Results 
Clinical features of (be palien, group (‘fable I). The 24 
mifients (17 men and 7 women) who had cmcr~~ncy coro- 
;ary bypass surgery (ssrgical group, were co;par&l w,,b 
the rem&ning 262 patienr, in :be ‘TAM, trial who did nor 
undergo such surgery. The indicaion for wrgery wil* lcfl 
main or equivalea coronary artery dwuw 17 7 palienir. 
coronary anatomy nnsuilable for angmpla\,y I” 4 pWe.d\ 
and unsuccessful coronary angioplasly m I3 pulientr. Pa. 
,ien,h who underwcn, cmereencv cur~erv were slichdv older 
and had a higher incidc& of a&&r wall &&rdk~l 
infarction (67 vrrsus 3W. The inbrcl-related aner~ WBI the 
lef, main or lef, anterior descending coronary arwry in 66.1% 
uf the wraical crow compared with 39% of the rcmainine 
patienls. ‘?he ini,ial lef, &en,ricular cjcclron fraclinn wa! 
lower in ,he w&xl croup 147 ? I I verws S? ? II%). ;md 
in 8 of the 24 p&n,,in ihir w&l g-aup hcmodyndmics 
were consiaa, wirh cardiogenic &ck (,ywlic arterial 
pressure <90 mm Hg Je@c \pulmonary wed&c pre\wrc 
>I.( mm HgI ia, Ihe hmc uf cardiac cuheterizalion abhough 
clinical shock <‘as nul prcxnt ai Ihc rmw of enrdllinerr, in 
wa< auumplsd in I4 p&:cn,9. Peri~Qen, coronary occlusion 
IW\ prxni m 3 of thex I4 pawn,\ before attempted 
:mgwplauy. .d IO palients had been randonided ,u imme- 
d:a,c .::>gm+iy according ic :be T,\M4! pro:aco:. A ie:: 
lllilill cnronilry ancry oCc,“SIon wa1 i”cccssf”u:ly di$Wd in 
.molhcr prwnr web cardioaemc shock before emcrgcncy 
bypa\\ wrgcry. In three patients. infarct arlery palacy 
could nut he axhwcd pharmacologically 3r mechanically 
before wrgery: two of these parent! had muluwsel coro- 
nary dwxw. and wrgery wa\ pctiomxd within 6 h of 
\ymplom onxt in all three p&n’*. Thw. infarct ancry 
patsnc) \lu* .ahwed !n ihe carhercrization laboraory hc- 
fore bypa*\ ruresry in ?I (88%) of 24 puien,c. 
Ikwuw bollmur u~rhcrcv iu{irrrirw. ECG ST xgmen, ele- 
va,ron wa\ nu,cd in I[ of ,he 14 !ga’:en,s undergumg cmo- 
nary ;mgmpla\ty. and recurrent chest pew dcvclopcd in I I of 
13 pa,irnl\ irho could be m,e~v~ewed. Angmplarly ~‘a* 
unwcce~\ful m 13 paticn,~ al (I rewll of rethrambosr\ I9 
pwicnr*i or DEC~UMW indmal disvxlion I4 paticmrl. Kc- 
,hromho+ charxlerwically ncc~rcd wifhin 20 min of an 
.ippxrenrly wccensful coronary dilrdmn and was uwdly 
refrac,ory ,o &,emp,s $1, repeal diladon and inlracoronary 
infuvon of tiwx phlsminogw aclivalor (IUI. A coronary 
perfuvon calheler (Advanced Cardmvawdar Systems) ww 
kred into ,he i&arc, ar,cry bcforc wrgery in I I of ,hc I3 
unwcce5*ful an~iopla~ly. and cornwry Row wx docu- 
mentcd angiographically in each. No, all pSien,% wi,h un- 
wcw%tol rmmediate angiuplasty rn rhe lAM, lrlal had 
crncrgency bypasi wgery. Palien,~ were awarcd on dn 
indiwdual basis for clinical and her :dynamic d&l ~ggc*,- 
ing I) I~NEC. vrahle jenpardiad myi cardml bed or w:ere 
mubivcw! cnronary disease. P&n,\ with a small mbrc~- 
relaled ar,ery and B limited mfarc, terrrtory were no, lrcaled 
with rurgcry df,er unsuccessful angio?lns,y. 
@pass wwry mul(s. Cardmpulmonary bypass wit\ ix- 
r,i,u,ed 7 3 ? 1.9 h r&r the UBY, ofchw pain. An average 
of 3 ? I distal an&,omoscc were performed wilh the 
infwc,~rclwd anery being gr.+zd wing a raphcnous vrm 
graf, in 20 paentr and the leh rnternal mammary ar,er) in 4. 
There were no intraoperalivc deaths. One p&n, w,h 
profound left ventriculw decompwmon after lcf, main CUT- 
unary awry occlusion and wcerrful ~goplar,y required 
plarcmcn~ of a mech.mical left ventricular assist dcwce in 
order 10 be removed from cardiopulmonary bypass. 
Hospital course. Significanl portoperalivc complicalionr 
were nolcd in wveo oalxcnlr (29%). There WFM no hosmlal 
death\ in rhe 16 pa&~ with scahle preoperalive hcm;dy_ 
ilarmcs. and 3 hospital deaths (38%) among 8 patients wilh 
preoperative cardiogcnic shock. One patient with pcnistcnl 
profound cardmgenic shock and disseminated intravascular 
cosgtdauon died 2 days postopcralivcly. A second patienl 
died suddenly of a primary Fardiac arrhythmic event IO days 
portoperalivcl,. and a lhird patient died of cardiogenic 
shock and rc*pirator) faihwa 2 days po~lopcratively. A 
nonhcmorrhagac woke with minimal residual ncumlogic 
d&it WB’ noted porlopemtively in one 70 year old women. 
Myxedema cuma was dmgnosed in another woman after 
roid applementalion during a 38 duy hospital stay. The 
average toial ho\pitnl svsy was 13 + 5 days (racge 6 10 
38) 
Hemurrhagc. Postoperatively. one p&w1 developed 
overt dlwminated imr.wwu!ar coag~l&x that was 
thought to he rccondary IV prob-acted cardiogcnic shock and 
the uw uf a mcchaoical left ventricular atis! device. Three 
other Patients had Ggniticanl postoperitlive hleeding neces- 
sitinng wrgical reexploration. which identificti a discrete, 
surgically correctable cnube of bleeding (vein graft branch) in 
one p&n!. Hemorrhage in the other two pebenta IX%> was 
behsvcd 10 be cons~em with B more generalired abnormal- 
ity in hemoari\. powhly related 10 preopcralivc Ihrom- 
holytic trca:ment. Poitopcratively. the averale chest tube 
drainage during the Rrst 24 h for palients not requiring 
surgical recxploralion was I.202 ml (range 220 Lo 4.425). and 
the lowest hemoglobin level was 9 2 1 8. During the first 24 
h after owrat~on. patient, rcceivcd an a~craw of 5.6 LI 
(range 0 I; IS) of packed red cells. 4 U (range 01; 14) of fresh 
hoan plaxxa. 3.9 U (range 0 lo 18) of cryoprecipitate and 3 
pack\ lrange 0 lo 20) of platelctr. 
Ckaiigs ifi :cfi i.entiiclilw fun&n. Pdiiid iei:y ad lalc 
venir~ulograms were availahie for 15 paienls. Paired ven- 
tr~ulog~ama were no1 avedeble for three pat!ents who died 
in the hospital. three patients with prcopernlive cardiogenic 
shock or cardiopulmonary rewscilabon. or both and were 
of tcchnsally inadequate quaky for analysis in three pa- 
tient\ 
70 1 
or regional (inhrcl ronc) left vcnlricular function [Pig. 2;. 
Individual patient data for global as well as regional MWct 
and noninfarct LOOF) left ventncular function are dep:?ted to 
Figure 3 for p&ma with single vetrel coronary artery 
diveax and in Figure 4 for plients having mulwcsscl 
coronary artery diseasr. lmprovemenl io nonisfarct zone 
left venlriculilr function was frequenllp not:d in piatiems 
with multivebsel coronary arwry diseae. 
,i I 
Emewncy coronary artery bypass surgery was pcr- 
formed in 24 (6%) of 386 conseculive ~atienls enrolled m a 
trial of inlravenouz tissue plasminogen aclivalor therapy LPU 
percutaneous angioplasty for acuLe myocardml mfxclian. 
Unlike prior reported series (15-19) of bypa .z rurgery w’ar- 
ment for acute myocardi;il infarction. in the prtsanl &a. 
surgery was nof wed LU iniliatc mynr.avdial reperfusion in 
!he majori!y of patients. but inrtcad served IU maml;dn 
perfusion already achiewd by pharmacologic or coronary 
angioplaaly Lechniqua. or both. The present wnes thus 
drmonrlrates that emergency bypasr surgery can bc uxd a\ 
one ccmponrnr in B ~egucnt~al pharmacologic-mechan,c*i 
Becaux of ifs care and rapidity of admmntnlion. mtra- 
venw thrumbolylic rherapy currently appears 10 be the 
Sclecliou of palients lor emergency bypass surgery (Table 
2). Our expencncc in Ihe proenl sludy ha> been helpful in 
constructing potenGal indications for the u\e of emergency 
comnery hypw rorgery in 51 sequcniial rcperfusion wal- 
egy. Thz recommendalion for surgery is determined by the 
presence of lbigh ri\k coronary anafomy in padents wilh 
pharmacologic coronary recunalizalion. moltiveascl coro- 
narv dnxlre with evidence of zlobal Ien venlricular comoro- 
mise or unucce\rful coronary angioplwy in palients with 
climcnl cwdencc ofa PargejeopardiLed bul viable myocardial 
bed. .A\ wggested by the data from Dewood et al. 115.16l. 
failure to rccanalizc the iniarci-r&led artery ma) be another 
indication for operation if surgery can bc performed within 
6 h of \ymplom omel. In this subject of p&n& in whom 
surgery i) used to in&e myocardial repcrfucion, improve- 
ment of left venlricular function and long--term wvivid has 
been demonslrarcd for pet~ents opernled on within 6 h of 
symplom onset (15.16). The ,common basis of these indica- 
tion\ 15 the presence of a large quanlity of jeopardized 
myocardium in which pcrfwion cannel be awrcd by phar- 
macologic or ~CKUMI~OU mechanical techniquer. Al- 
though the presence of preoperative cardlogcnic shock is a 
poor propnow sign. the ho~pltal mondlily we for this 
group m our scr~c\ 08%) and in previous published wries 
~15.17.1L9-2?) (wmolativc monabty we 29.7%) appears cn- 
cowaging when it i9 compared wiih rewlt* of mcdicul 
therapy m thi\ group of patient, ‘Thew recommendations 
are hacd on ourcrpericncc and thal ofothers. Performance 
of a randomized clinical trial 10 lest these polcntial indica- 
lion, will be needed before they can be adopted as routine 
pmclice. 
Rleeding complicalionu. Clot Nibrio) specificily with rela- 
tive preservadon of circulating congulalion faclors and an 
increased efficacy of coronary recanalization make lissue 
plasminogen aclivalor an atlraclivc librinolylic agenl for 
coronary thrombolysis (23.24). II has been postulated (25) 
lhat emergency bypass surgery may be ~dfer after tissue 
plasminogen activalor therapy than after slreptokinaae ther- 
apy because of Ihe lxk of a hyslemic lytic state with Ihe 
former agcnf. Significant posloperative hemorrhage was 
noted in 4 of the 24 patients in the present series. In one 
patienl, hemorrhage (disseminated imravoscular coagula- 
lion) was thought 10 be secondary 10 B mechanical left 
ventricular assisl dewce and protracted cardiogenic shock, 
In noother r&ent. surgical reexploration defined a diwrele. 
surgically correctable cause for bleeding. Thus, paslopera- 
live hemolrhare believed 10 he excessive and not attribut- 
able Lo caoses%her Ih,m preoperative thmmbolytic therapy 
witb Iissuc plasminogen activaw was noted in 2 (8%) of the 
!4 padems. 
Although no randomized comparison of emergency sur- 
gery after thromholysis wilh tissue plasminogen activator or 
sIreptokinaae is available. one carefully detailed study (18) 
of pntienls undergoing emergency surgery aflcr weptoki- 
nase-mediated coronary thrombolysis repaned greater porl- 
operative lransfusion requirements lhan were noted in Lhe 
present series of paients. Althouch no firm conclusions can 
be drawn from &au data. the short hall-life and relaively 
fibrinogen-sparing associated with the use of tissue plasmi- 
nogen acdvafor may be beneficial when cmcrgcncy rorgery 
musl be performed. Perioperative fibrinogen data from the 
present emergency surgery series are incomplete and lhur 
inadequate from which to draw concIu~~ons. fhe presence or 
abscncc of a byslemic lytic Gate was nrt nnown by the 
investigator and thus did not influence patent selection for 
emergency sw&:ry. Rerause of the r;sk of coronary rcoc- 
elusion. we did not termmate the inirwenws infusion of 
tissue plasminogen activator until the omet of the surgical 
procedure. 
Resmvstlon ofleft vcnlriculpr bnction. 0, soikmg degree 
of preservation in global and regional Imixct zone) MI 
ventricular function was seen in our patient; after coronary 
revascularization was induced by cmergcncy surgery [Fig. 
I). It must he emphasized lhaf myocardial reperfusion had 
been achieved by pharmacologic or mechanical meaor. or 
both. in the vast maioritv (88%) of these oaticntr before 
surgery. Thus, surgc~y dih not iniliatc my&dial rcpcrfu- 
sion. but instead maintained perfusion already achieved by 
other means. In tne majority~(W%) of patients with uowc- 
cessful coronary angioplasty. a coronary perfuusion calheter 
was placed into the infarct-r&&cd artery to mechanically 
maintain myocardial perfusion enroute to surgery. There- 
fore, the degree of pr&ervatian in left ventricular functwn 
achieved in the presenr series cao bcrt be attributed 10 the 
sequential pharmacologic-mechanical and wb,equent surgi- 
cal reuascularization strategy applied. Although some de- 
gree of enhancement in left vcntriculx fuunctian may be 
attributable LO an increase in circulating calecholamines and 
other factors after major cardiac surgery 126.27). the magni- 
tude of such changes appears small in compariwn with the 
improvement noted m thr present series. In addition. vale- 
d&ion ofcompaisons between regions of the ~amc ventricle 
before and after cardia; lurgery has oat been reporled. 
However. we did not observe improvement in global left 
ventr~culi~r ejection fraction from !he time of study entry to 
ptcdwhargc for the TAM1 trial smdy group ia LI .xh~li 
whrther or not coronary angiopiasly was performed crnc~- 
gently t 10). In8 separate analytic, a h&r Tlhll Row grade 
on the ‘34 min angiogram. a mow depressed acute left 
ventricular eJection fractmn and the “cc of emergency by- 
past rurgcry were independently associated with subsequent 
improvcmcnt in left ventncular ejection fraction bcfoare 
hospital discharge. even after controlling for the influence of 
other cbo~al and anaiosradic factors. Ncnhcr the tnc of 
obscrwd (II the ;&em series did not appear 10 d&d on 
ibe timing of surgical inlervcntion relalive to bymplom oow 
(~6 wrw~ >6). Although the number of observalions war 
mn vn;~!I 10 allow a definnive coocIus~oo. thic important 
obrcrmt~on moot likely reflects the sequential rcperforion 
~~~tegy used and the reeslab!ishment of coronary blood Row 
by pharmacologic and mechanical means in the majority of 
patient< hcfore surgery. Thus, early initial coronary rcper- 
fuxon may be the pivotal event for wb,equent func ionai 
recovery of the myocardium. 
P~rMrrs nralriversel roron~~~ nrrrry dirrosr appcsr 
10 have a greater magnitude of preservati.m /? global left 
renfr~olar function than do patienls with tingle vessel 
disease. although improvement in infarct zone funclion was 
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